Open Access
1 July 2006 Effect of optical tissue clearing on spatial resolution and sensitivity of bioluminescence imaging
Author Affiliations +
Abstract
In vivo bioluminescence imaging (BLI) is a powerful method of in vivo molecular imaging based on the use of optically active luciferase reporter genes. Although this method provides superior sensitivity relative to other in vivo imaging methods, spatial resolution is poor due to light scattering. The objective of this study was to use hyperosmotic agents to reduce the scattering coefficient and hence improve spatial resolution of the BLI method. A diffusing fiber tip was used to simulate an isotropic point source of bioluminescence emission (550 to 650 nm). Mouse skin was treated in vitro and in vivo with glycerol (50%, 30 min) and measurements of optical properties, and imaging photon counts were made before, during, and after application of glycerol to the skin sample. Glycerol application to mouse skin had little effect on the absorption coefficient but reduced the reduced scattering coefficient by more than one order of magnitude. This effect was reversible. Consequently, the spot size (i.e., spatial resolution) of the bioluminescence point source imaged through the skin decreased by a factor of 2 (550-nm light) to 3 (650-nm light) after 30 min. Simultaneously, an almost twofold decrease in the amount of light detected by the BLI system was observed, despite the fact that total transmission increased 1.7 times. We have shown here that multiply scattered light is responsible for both observations. We have shown that applying a hyperosmotic clearing agent to the skin of small rodents has the potential to improve spatial resolution of BLI owing to a reduction in the reduced scattering coefficient in the skin by one order of magnitude. However, reducing the scattering coefficient reduces the amount of light reaching the camera due to a reduction in the amount of multiply scattered light that reaches the camera aperture and thus reducing the sensitivity of the method.

1.

Introduction

Photoactive reporter genes allow optical imaging of in vivo biological activity, such as the spatial and temporal distribution of gene expression, 1, 2, 3, 4, 5, 6, 7 host-pathogen interactions, 8, 9, 10, 11, 12, 13 tumor growth and metastasis, 14, 15, 16, 17, 18, 19 and transplant studies.20, 21 While over 30 bioluminescence systems exist in nature, all have in common a luciferase-catalyzed oxidation of a luciferin substrate to produce light.22 Unlike fluorescence systems [i.e., green fluorescence protein (GFP)], bioluminescence imaging (BLI) requires no excitation source, which simplifies the optics involved in the imaging process, allows for detection of light emission from deeper tissues, and facilitates quantitative analysis. In addition, light emission from the chemiluminescent oxidation of the luciferin substrate emits broadband light that peaks at 563nm ( 590nm at body temperature of 37°C ) but spans wavelengths from 500 to 700nm , thus allowing deep tissue penetration (on the order of several centimeters), in particular of the red parts of the emission spectrum.23, 24 The main drawbacks to using bioluminescence for in vivo imaging are the extremely low intensity of light produced and the poor resolution due to tissue scattering.

Hyperosmotic agents such as glycerol, dimethyl sulfoxide (DMSO), Trazograph, polyethylene glycol, polypropylene glycol- (PPG) and polyethylene glycol- (PEG) based prepolymer mixture, and glucose have been shown to transiently clear tissue within 30min of application in hamsters and rats25, 26, 27 and even in humans 28, 29, 30, 31 both in vitro and in vivo. Increases in transmission of up to 200% and decreases of the reduced scattering coefficient of a full order of magnitude were reported. Clearing is believed to be due to index matching of the extracellular fluid with the tissue solid components (mainly collagen) and dehydration due to osmotic pressure.

The objective of this study is to investigate if treating skin with a hyperosmotic agent (glycerol) in order to reduce scattering will improve the sensitivity and spatial resolution of bioluminescence imaging. This study consisted of four parts: in vitro measurement of tissue (i.e., mouse skin) optical properties, in vitro simulated BLI, in vivo macroscopic imaging, and in vivo simulated BLI.

2.

Materials and Methods

2.1.

In Vitro Optical Properties Measurement

A Perkin-Elmer Lambda-900 spectrophotometer with an integrating sphere setup was used to measure tissue optical properties. Transmission (%T) , diffuse reflectance (%R) , and thickness (d) for in vitro studies were measured for samples of excised albino friend virus B-type (FVB) mouse skin (2cm×2cm) , within 12h of sacrifice. Prior to the optical measurements, the samples were sandwiched between two microscope slides. Care was taken that no air bubbles remained between the tissue and the slides. Thickness of skin samples was determined by measuring the thickness of the sandwich and subtracting the thickness of the microscope slides. All thickness measurements were made using a digital caliper and the average of five independent thickness measurements was used for each sample. Skin samples were then treated by soaking in glycerol baths with concentrations of 25%, 50%, and 100% for 30min . After measuring transmission values, reflectance values and thickness, the skin samples were rehydrated by soaking in saline for 30min . Samples were measured for transmission and reflectance again after rehydration. Values for absorption coefficient (μa) and reduced scattering coefficient (μs) were calculated from the spectrophotometer data using an inverse adding doubling program.32 All optical property measurements were performed in triplicate (n=3) using samples from different mice.

2.2.

In Vitro Simulated Bioluminescence Imaging

After determining the tissue optical properties, an in vitro simulated bioluminescence study was performed. The goal was to match the conditions encountered in BLI, specifically, intensity and wavelength. A tungsten white light source was bandpass filtered at 550, 600, and 650nm [full width at half maximum (FWHM)=10nm ], then coupled into a 200-μm diameter optical fiber with a 500-μm diameter spherical diffusing fiber tip at the distal end, which provided an isotropic light source. The three wavelengths were chosen because luciferase-catalyzed bioluminescence has its highest intensities in the wavelength range of 500 to 700nm .23 The shorter wavelength components of this spectrum are attenuated by hemoglobin absorption, so the chosen wavelengths of light provided a realistic simulation of actual luciferase bioluminescence. The diffusing fiber was taped to the bottom of a petri dish ( 100mm diameter). A piece (2cm×2cm) of excised mouse skin was placed over the fiber tip on the bottom of the petri dish with the epidermal side facing the fiber and the subdermal side facing up. The sample was held in place by a metal retaining ring with an aperture large enough ( 1.5cm diameter) such that it did not block any light. For all experiments, a constant volume of 25ml of glycerol solution of 25%, 50%, or 100% concentration (v/v) was added to the petri dish such that a layer of glycerol, roughly 3-mm high was overlying the skin sample. The entire assembly of petri dish, fiber, skin sample, and glycerol was placed in the light-tight imaging chamber. The fiber was guided into the chamber via a double baffled black rubber seal to avoid stray light from entering the imaging chamber. Images were then taken with a liquid nitrogen-cooled, back-thinned, back-illuminated, deep depletion charge-coupled device (CCD) camera (Roper EEV 1300×1340 ). Background subtraction was performed on all images as a means of noise reduction. Image integration times of 5s were used and no on-chip binning was used. The setup is summarized in Fig. 1 . Intensity is reported as the integrated pixel intensity for a defined area of a CCD image at a specific time point relative to the first time point for each wavelength. Spot size is defined as the width of the section of the cross-sectional intensity profile where values are greater than a predefined threshold (100 photon counts).

Fig. 1

Schematic of the experimental setup. A bioluminescence point source was simulated by using bandpass filtered light ( 550nm , 600nm , or 650nm ) delivered via a 200-μm fiber to an isotropic diffuser tip. The same setup was used for in vitro (top left inset) and in vivo (bottom left inset) experiments.

041119_1_029604jbo1.jpg

Images were taken of the fiber alone, the fiber with overlying skin, and the fiber with overlying skin submerged in glycerol (time sequence). To minimize the effect of biological variation among skin samples, the experiment was designed to perform all three wavelengths in a single skin sample. This was accomplished by letting the camera controller take an image every 40s for a duration of 5s while rotating the three bandpass filters in front of the white light source every 40s to provide time points for each wavelength in 2-min intervals.

2.3.

In Vivo Macroscopic Imaging

Live mice were treated with transdermal glycerol injections and imaged over time. Eight-week old, female albino FVB mice were anesthetized with 0.015mlg body weight of a mixture of ketamine (6mgml) and xylazine (0.6mgml) given intraperitoneally. Administration of glycerol was accomplished by inserting a 21-gauge needle subdermally in the animal’s dorsal side, then lifting up and entering the dermis from the subcutaneous side. Approximately 0.2ml of either 50% or 100% glycerol were injected in 0.05- or 0.1-ml increments. Images of the skin in the live mouse were taken with a digital camera coupled to a 10× operating microscope before, immediately after, 30min , 60min and 24h post–glycerol application.

2.4.

In Vivo Simulated Bioluminescence Imaging

The in vivo simulated bioluminescence experiment used a similar setup to the in vitro simulated bioluminescence experiment (Fig. 1). The diffusing fiber was placed subdermally in the mouse after glycerol was injected transdermally. The injection procedure described for the in vivo macroscopic imaging study was used. Based on the findings of the in vitro study, the 600-nm wavelength light and 50% glycerol concentration were used. Photon counting images were taken at t=0 (pretreatment), 15, and 30min .

3.

Results

Figures 2 show the increase in transmission [Fig. 2a] and decrease in diffuse reflectance [Fig. 2b], respectively, after treating native skin with 50% glycerol for 30min (each line represents the average of three independent measurements). These figures also show that transmission and reflectance return to approximately their pretreatment values after rehydration with saline for 30min . The reduced scattering coefficient (μs) for skin [Fig. 3a ] decreases after 30min of 50% glycerol exposure and returns to very near its untreated value after rehydration. The absorption coefficient (μa) after 30min of glycerol exposure is nearly the same as in the untreated state [Fig. 3b]. The limited thickness of the mouse skin samples (220μm) causes the inverse-adding doubling (IAD) program to return values that are not meaningful for weakly attenuated wavelengths in the cleared skin samples. Nevertheless, it can still be seen that μs is reduced by approximately one order of magnitude for the wavelengths of interest.

Fig. 2

Total transmission (a) and reflectance (b) measurements of in vitro normal skin, glycerol treated skin (50%, 30min ), and skin treated with glycerol for 30min then placed in saline for 30min . In the spectral range of interest (550 to 650nm ), the total transmission increases (nearly two-fold) and the diffuse reflectance decreases (threefold to fourfold) due to glycerol application. Each line represents the average of three independent measurements (n=3) .

041119_1_029604jbo2.jpg

Fig. 3

Reduced scattering coefficient (a) and absorption coefficient (b) of in vitro normal skin, glycerol treated skin (50%, 30min ), and skin treated with glycerol for 30min then placed in saline for 30min . Each line represents the average of three independent measurements (n=3) . Optical properties were calculated from transmission and reflectance measurements using an IAD program. In the spectral range of interest (550 to 650nm ), the absorption coefficient is unaffected by the glycerol treatment, while the reduced scattering coefficient drops by nearly one order of magnitude.

041119_1_029604jbo3.jpg

Plots of intensity and spatial resolution for three wavelengths for the simulated bioluminescence experiment are shown in Figs. 4a and 4b . Both values decrease with increasing glycerol (50%) exposure. The maximum intensity decrease after 1800s was 38.8% for 550-nm light, 48.4% for 600-nm light, and 42.6% for 650-nm light. Spot size decreased by 51.9% for 550-nm light, 60.0% for 600-nm light, and 68.0% for 650-nm light after 1800s . The measured spot size was smaller for the shorter wavelength light at all time points.

Fig. 4

Integrated photon intensity (photon counts) (a) and spot diameter (b) measured by the imaging system through skin as a function of time of exposure to glycerol. Both parameters decrease with time (and hence with decreasing the reduced scattering coefficient).

041119_1_029604jbo4.jpg

Figure 5 summarizes the spatial resolution data for the simulated bioluminescence study. Two trends are apparent: increasing spot size with decreasing glycerol concentration and increasing spot size with longer wavelength. Notably, 50% and 100% glycerol concentrations result in significantly decreased spot sizes (i.e., better spatial resolution) compared to native tissue (p<0.001) while there is no statistically significant difference between native skin and 25% glycerol-treated skin.

Fig. 5

Effect of glycerol concentration on spot size reduction of skin in vitro for different wavelengths. Note that 25% glycerol is ineffective in clearing skin after 30min and shows values that are not different from native skin. In all cases, the spot size for 650-nm light is larger than that for 550-nm light as expected. However, the change in spot size due to glycerol is most significant at the 650-nm wavelength.

041119_1_029604jbo5.jpg

The results of the in vivo macroscopic imaging study are shown as Fig. 6 . Figure 6a shows a section of mouse skin 30min after injection of 0.2ml of 100% glycerol. The same section of skin is shown 24h later [Fig. 6b] when the clearing effects have reversed.

Fig. 6

Image of in vivo mouse skin 30min after injection of 0.2ml 100% glycerol (a) and 24h after (b) glycerol application when clearing is reversed. The left top part of the image shows the area where glycerol was applied, the right bottom shows an area of normal skin. The luminescent spot (for 650nm ) thresholded at photon counts > 100 , generated by the 500-μm diameter diffusing fiber is shown in (a) in both the cleared and untreated portion of the skin. Note that the spot size reduced by a factor of approximately 2 in cleared skin.

041119_1_029604jbo6.jpg

Integrated intensity and spot diameter for the in vivo simulated BLI experiment are shown in Figs. 7a and 7b , respectively. Both plots show a decrease of intensity and spot diameter, respectively, as the tissue clears with time.

Fig. 7

Effect of glycerol application in vivo on integrated photon intensity (a) and spot diameter (b) measured by the imaging system through skin of a live mouse before, at 15min , and at 30min of glycerol application. Note that both parameters decrease with time (and hence with decreasing the reduced scattering coefficient) similar to what was seen in vitro.

041119_1_029604jbo7.jpg

4.

Discussion

In this study, we have investigated the use of glycerol as a tissue clearing agent in order to improve the sensitivity and spatial resolution of in vivo BLI. To address the feasibility of this approach, we conducted a set of experiments determining the optical properties of skin in vitro and designed a set of experiments to study the effects of skin clearing in experiments in which a diffusing fiber tip was used as a simulated and constant (point) source of bioluminescence emission.

The optical properties of mouse skin measured for the skin before treatment, after 30min of glycerol (50%) exposure, and after rehydration with saline for 30min (Figs. 2 and 3) were consistent with previous studies on rat skin and hamster skin.26 Tissue optical clearing is believed to be due to a decrease in the reduced scattering coefficient by index matching of extracellular fluid and tissue solid components. Within the spectral range of interest (550 to 650nm ) total (diffuse) transmission increased on average by a factor of 1.70 and diffuse reflectance decreased on average by a factor 3.37. After 30min of saline rehydration, both transmission and reflectance values returned to within 10% of their untreated values. This was confirmed by the results of an IAD program, which calculated μs and μa from the spectrophotometer data. Over the spectral range of interest, the reduced scattering coefficient (μs) decreased on average by approximately one order of magnitude, while the absorption coefficient (μa) was nearly constant ( <5% change). The IAD model was unable to compute meaningful results for wavelengths > 450nm in cleared skin due to a combination of low scattering combined with the relatively thin mouse skin thickness. Nevertheless, the reduction in diffuse reflectance, the increase in transmission, and the calculated optical properties in the range where the model did converge are in general agreement with data published on rat and hamster skin.25, 26, 27

The decrease in light detected by the camera, seen after glycerol application (Fig. 4) in the in vitro simulated bioluminescence experiment was unexpected and in apparent conflict with the integrating sphere measurements, which showed a 1.7-fold increase in transmission. However, we speculate that this apparent discrepancy can be explained by the fact that fundamentally the two measurements are different. Traditionally, a double integrating sphere setup is used to measure total transmission and diffuse reflectance. In this setup, all of the light incident on the tissue is accounted for by one sphere or the other. More specifically, with regards to the transmission measurements, all transmitted light (i.e., total transmittance), irrespective of the angle with the tissue normal, is captured in this measurement. Hence, if the reduced scattering coefficient decreases as is the case in skin treated with glycerol, the total attenuation coefficient decreases, and hence, the overall transmission of light through the tissue increases. In contrast, the imaging geometry where the camera is positioned approximately 50cm above the tissue sample and has an effective aperture of roughly 2.5cm detects only light that is emitted within the acceptance cone angle of the camera (7deg) . The decrease in light reaching the camera in cleared skin compared to native skin is believed to be due to the reduction of multiple scattering events. In the native skin, light emitted in a direction that would put it outside the camera’s acceptance angle can be multiply scattered and redirected to emit from the tissue in a direction within the camera’s acceptance angle. The net result of this is a decrease in light detected by the camera (causing a decrease of approximately 40%) when the reduced scattering coefficient of the sample decreases (by a factor of 10), even though the total transmission of light through the sample is increased. We hypothesize that this geometric effect is also responsible for the apparent conflict between our imaging data and data published by Vargas 27 who showed increased fluorescence detected when skin was cleared and He, 33 who showed increased signal detection in low light level imaging applications after tissue clearing. In both these studies, different photon collection geometries were used. Vargas used a multifiber probe consisting of 200-μm diameter optical fibers with a NA of 0.2 (acceptance angle 12deg ) in contact with the tissue. In the study by He, the imaging geometry was not reported and apparently not considered in their Monte Carlo simulations. In addition, significantly thicker tissue samples were used, making a direct comparison difficult, if not impossible. Nevertheless, both these studies used geometries that are different from the typical BLI setup that employs a 1-in aperture roughly 50cm away from the tissue surface. We conducted two experiments to verify our multiple scattering hypothesis. First, we imaged the fiber tip under a layer of scattering liquid consisting of polystyrene microspheres (diameter 0.954μm ) in decreasing concentrations (and hence decreasing scattering coefficients). The setup was similar to Fig. 1 but with the tissue layer replaced by scattering liquid. In this experiment (Fig. 8 ), we found that as μs is increased from 0 to 3mm1 , light reaching the camera increases. When μs was increased beyond 3mm1 , light reaching the camera decreases. The net effect of changing the reduced scattering coefficient 10mm1 (native skin) to <1mm1 (cleared skin) is a reduction of light reaching the camera. This is consistent with our observation in native and clear skin. As we continue to increase μs , the slope of the curve changes and light levels reaching the camera start to decrease. The second experiment that was conducted to verify our hypothesis consisted of a Monte Carlo simulation. Using an isotropic light source underneath a slab geometry with the optical properties of normal and cleared skin, we determined the transmitted light as a function of radius and angle. Plots were generated of the light reaching the plane of the camera as function of radius. In this scenario (Fig. 8), we confirmed the data from the microsphere experiments and found that a combination of thin tissue layer, constant μa , and a reduction in μs from 10mm1 to less than 1mm1 leads to a decrease of light transmission within the acceptance angle of the camera, despite the fact that the total transmission increases. Although the decrease in intensity was not the desired effect, it may be a tradeoff for the increase in spatial resolution.

Fig. 8

Photon intensity detected by the imaging system as a function of the reduced scattering coefficient. Experimentally () , a serial dilution of polystyrene microspheres was made and simulated bioluminescence from the diffusing fiber tip was measured. Simulation results () were obtained from Monte Carlo simulations with the appropriate geometry to simulate light collection within the cone angle and aperture of the detector.

041119_1_029604jbo8.jpg

Glycerol application caused a decrease in spot size [Fig. 7a] ranging from 51.9% for 550nm light to 68.0% for 650nm light. The difference in resolution improvement between the wavelengths used is believed to be due to absorption (and hence the shorter mean free path) of shorter wavelength light by hemoglobin. Higher glycerol concentrations were also shown to be more effective at improving spatial resolution at 30min postinjection (Fig. 5). Notably, 100% and 50% glycerol are effective in reducing the imaged spot size (i.e., increasing spatial resolution), while 25% glycerol was not able to cause changes in spot size that were significantly different from native tissue. This is due to the higher osmotic pressure of the higher concentration of agent.26, 27

The in vivo macroscopic imaging study (Fig. 6) showed that, in accordance with previous studies, gross subdermal structures normally obscured by turbid tissue can be made visible by treatment with hyperosmotic agent. It was also shown that the clearing effects reversed 12 to 24h after injection.

Penetration of optical clearing agents through intact skin (in vivo) is minimal and extremely slow. This has been attributed to the fact that these agents are hydrophilic and penetrate the lipophilic stratum corneum poorly. In this study, we circumvented this problem by injecting the clearing agent directly in the skin (intradermally). Subdermal injections had no noticeable clearing effects. Given the relatively small thickness of the tissue (220μm) , it is difficult to inject the necessary amount (0.2ml) of glycerol. It was found that relatively high glycerol concentrations (50 to 100%) were necessary to achieve clearing within the desired time frame (15 to 30min ). At this concentration, the solution has a high viscosity, further increasing the difficulty of injection.

Promising recent work by Khan, who have explored a number of different skin clearing agents, has shown that a combination of Food and Drug Administration–approved lipophilic PPG based polymers and hydrophilic PEG is an effective, topically applied skin clearing agent. Although we have not tried this agent in mice, in vitro and in vivo results in humans suggest that it does not have the problems associated with glycerol.28

The results of the in vivo simulated bioluminescence experiment [Figs. 7a and 7b] were consistent with the trends seen in the in vitro experiments (Figs. 4 and 5). A 41.8% decrease in integrated intensity and a 38.5% decrease in spot size were seen 30min postinjection. Although we limited our tissue clearing to the clearing of skin for practical reasons (it is difficult to obtain adequate diffusion of the agent in thicker layers, especially in vivo), BLI is particularly useful for the imaging of processes that occur several millimeters or even centimeters below the tissue surface. For those cases, clearing only the skin (200 to 300μm in thickness in a typical mouse) will have a significantly reduced effect. Nevertheless, it is conceivable to extend this approach to clearing deeper tissues layers, in which case, spatial resolution is significantly improved and evidence suggests that the photon flux may in fact be improved,33 depending on the imaging geometry.

5.

Conclusions

In summary, we have shown that applying a hyperosmotic clearing agent to skin of small rodents has the potential to improve spatial resolution of BLI owing to a reduction in the reduced scattering coefficient in skin by one order of magnitude. In contrast, reducing the scattering coefficient reduces the amount of light reaching the camera due to a reduction in the amount of multiple scattered light that reaches the camera aperture and thus reducing sensitivity of the method. Tissue thickness and imaging geometry appear to be the critical factors that determine the effect of tissue clearing on spatial resolution and sensitivity.

Acknowledgments

The authors want to thank Dr. Rudolph Verdaasdonk (Utrecht University, The Netherlands) for providing the diffusing fiber tip used in these experiments. Funding for this research was provided by grants from the Vanderbilt In Vivo Imaging Center (VIVID) (No. NIH P20 CA86283), the Diabetes Center Pilot and Feasibility Project (No. NIH–NIDDK P60 DK20593), and the NSF Research Experience for Undergraduates (REU) (No. EEC–9820566).

References

1. 

D. A. Benaron, P. R. Contag, and C. H. Contag, “Imaging brain structure and function, infection and gene expression in the body using light,” Philos. Trans. R. Soc. London, Ser. B, 352 (1354), 755 –61 (1997). https://doi.org/10.1098/rstb.1997.0059 0962-8436 Google Scholar

2. 

R. T. Sadikot, E. D. Jansen, T. R. Blackwell, O. Zoia, F. Yull J. W. Christman, and T. S. Blackwell, “High-dose dexamethasone accentuates nuclear factor-kappa b activation in endotoxin-treated mice,” Am. J. Respir. Crit. Care Med., 164 (5), 873 –78 (2001). 1073-449X Google Scholar

3. 

C. H. Contag, S. D. Spilman, P. R. Contag, M. Oshiro, B. Eames, P. Dennery, D. K. Stevenson, and D. A. Benaron, “Visualizing gene expression in living mammals using a bioluminescent reporter,” Photochem. Photobiol., 66 (4), 523 –31 (1997). 0031-8655 Google Scholar

4. 

C. H. Contag, D. Jenkins, P. R. Contag, and R. S. Negrin, “Use of reporter genes for optical measurements of neoplastic disease in vivo,” Neoplasia, 2 (1–2), 41 –52 (2000). https://doi.org/10.1038/sj.neo.7900079 1522-8002 Google Scholar

5. 

R. T. Sadikot, L. J. Wudel, D. E. Jansen, J. P. Debelak, F. E. Yull, J. W. Christman, T. S. Blackwell, and W. C. Chapman, “Hepatic cryoablation-induced multisystem injury: bioluminescent detection of NF-kappaB activation in a transgenic mouse model,” J. Gastrointest Surg., 6 (2), 264 –70 (2000). 1091-255X Google Scholar

6. 

N. Wu, S. Opalenik, J. Liu, E. D. Jansen, M. G. Giro, and J. M. Davidson, “Real-time visualization of MMP-13 promoter activity in transgenic mice,” Matrix Biol., 21 (2), 149 –61 (2002). 0945-053X Google Scholar

7. 

N. J. Wu, E. D. Jansen, and J. M. Davidson, “Comparison of MMP-13 Expression In Free-Electron Laser and Scalpel Incisions During Wound Healing,” J. Invest. Dermatol., 21 (4), 926 –32 (2003). 0022-202X Google Scholar

8. 

C. H. Contag, P. R. Contag, J. I. Mullins, S. D. Spilman, D. K. Stevenson, and D. A. Benaron, “Photonic detection of bacterial pathogens in living hosts,” Mol. Microbiol., 18 (4), 593 –603 (1995). https://doi.org/10.1111/j.1365-2958.1995.mmi_18040593.x 0950-382X Google Scholar

9. 

G. R. Siragusa, K. Nawotka, S. D. Spilman, P. R. Contag, and C. H. Contag, “Real-time monitoring of Escherichia coli O157:H7 adherence to beef carcass surface tissues with a bioluminescent reporter,” Appl. Environ. Microbiol., 65 (4), 1738 –45 (1999). 0099-2240 Google Scholar

10. 

H. L. Rocchetta, “Validation of a noninvasive, real-time imaging technology using bioluminescent Escherichia coli in the neutropenic mouse thigh model of infection,” Antimicrob. Agents Chemother., 45 (1), 129 –37 (2001). 0066-4804 Google Scholar

11. 

K. P. Francis, D. Joh, C. Bellinger-Kawahara, M. J. Hawkinson, T. F. Purchio, and P. R. Contag, “Monitoring bioluminescent Staphylococcus aureus infections in living mice using a novel luxABCDE construct,” Infect. Immun., 68 (6), 3594 –600 (2000). 0019-9567 Google Scholar

12. 

K. P. Francis, “Visualizing pneumococcal infections in the lungs of live mice using bioluminescent Streptococcus pneumoniae transformed with a novel gram-positive lux transposon,” Infect. Immun., 69 (5), 3350 –58 (2001). 0019-9567 Google Scholar

13. 

G. D. Luker and D. A. Leib, “Luciferase real-time bioluminescence imaging for the study of viral pathogenesis,” Methods Mol. Biol., 292 285 –96 (2005). 1064-3745 Google Scholar

14. 

P. R. Contag, I. N. Olomu, D. K. Stevenson, and C. H. Contag, “Bioluminescent indicators in living mammals,” Nat. Med., 4 (2), 245 –47 (1998). 1078-8956 Google Scholar

15. 

A. Rehemtulla, L. D. Stegman, S. J. Cardozo, S. Gupta, D. E. Hall, C. H. Contag, and B. D. Ross, “Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging,” Neoplasia, 2 (6), 491 –95 (2000). https://doi.org/10.1038/sj/neo/7900121 1522-8002 Google Scholar

16. 

M. Edinger, T. J. Sweeney, A. A. Tucker, A. B. Olomu, R. S. Negrin, and C. H. Contag, “Noninvasive assessment of tumor cell proliferation in animal models,” Neoplasia, 1 (4), 303 –10 (1999). https://doi.org/10.1038/sj/neo/7900048 1522-8002 Google Scholar

17. 

T. J. Sweeney, V. Mailander, A. A. Tucker, A. B. Olomu, W. Zhang, Y. Cao, R. S. Negrin, and C. H. Contag, “Visualizing the kinetics of tumor-cell clearance in living animals,” Proc. Natl. Acad. Sci. U.S.A., 96 (21), 12044 –49 (1999). https://doi.org/10.1073/pnas.96.21.12044 0027-8424 Google Scholar

18. 

M. Vooijs, J. Jonkers, S. Lyons, and A. Berns, “Noninvasive imaging of spontaneous retinoblastoma pathway-dependent tumors in mice,” Cancer Res., 62 (6), 1862 –67 (2002). 0008-5472 Google Scholar

19. 

A. Wetterwald, “Optical imaging of cancer metastasis to bone marrow: a mouse model of minimal residual disease,” Am. J. Pathol., 160 (3), 1143 –53 (2002). 0002-9440 Google Scholar

20. 

M. L. Koransky, T. K. Ip, S. Wu, Y. Cao, G. Berry, C. Contag, H. Blau, and R. Robbins, “In vivo monitoring of myoblast transplantation into rat myocardium,” J. Heart Lung Transplant, 20 (2), 188 –189 (2001). 1053-2498 Google Scholar

21. 

M. Fowler, “Assessment of pancreatic islet mass after islet transplantation using in vivo bioluminescence imaging,” Transplantation, 79 (7), 768 –76 (2005). 0041-1337 Google Scholar

22. 

T. Wilson and J. W. Hastings, “Bioluminescence,” Annu. Rev. Cell Dev. Biol., 14 197 –230 (1998). https://doi.org/10.1146/annurev.cellbio.14.1.197 1081-0706 Google Scholar

23. 

B. W. Rice, M. D. Cable, and M. B. Nelson, “In vivo imaging of light-emitting probes,” J. Biomed. Opt., 6 (4), 432 –40 (2001). https://doi.org/10.1117/1.1413210 1083-3668 Google Scholar

24. 

H. Zhao, T. C. Doyle, O. Coquoz, B. W. Rice, and C. H. Contag, “Emission spectra of bioluminescent reporters and interaction with mammalian tissue determine the sensitivity of detection in vivo,” J. Biomed. Opt., 10 (4), 41210 (2005). 1083-3668 Google Scholar

25. 

V. V. Tuchin, I. L. Maksimova, D. A. Zimnyakov, I. L. Kon, A. H. Mavlyutov, and A. A. Mishin, “Light propation in tissues with controlled optical properties,” J. Biomed. Opt., 2 (4), 401 –17 (1997). https://doi.org/10.1117/1.429841 1083-3668 Google Scholar

26. 

G. Vargas, E. K. Chan, J. K. Barton, H. G. Rylander III, A. J. Welch, “Use of an agent to reduce scattering in skin,” Lasers Surg. Med., 24 (2), 133 –41 (1999). https://doi.org/10.1002/(SICI)1096-9101(1999)24:2<133::AID-LSM9>3.0.CO;2-X 0196-8092 Google Scholar

27. 

G. Vargas, K. F. Chan, S. L. Thomsen, and A. J. Welch, “Use of osmotically active agents to alter optical properties of tissue: effects on the detected fluorescence signal measured through skin,” Lasers Surg. Med., 29 (3), 213 –20 (2001). https://doi.org/10.1002/lsm.1110 0196-8092 Google Scholar

28. 

M. H. Khan, B. Choi, S. Chess, M. K. K, J. McCullough, and J. S. Nelson, “Optical clearing of in vivo human skin: implications for light-based diagnostic imaging and therapeutics,” Lasers Surg. Med., 34 (2), 83 –85 (2004). https://doi.org/10.1002/lsm.20014 0196-8092 Google Scholar

29. 

M. H. Khan, S. Chess, B. Choi, K. M. Kelly, and J. S. Nelson, “Can topically applied optical clearing agents increase the epidermal damage threshold and enhance therapeutic efficacy?,” Lasers Surg. Med., 35 (2), 93 –95 (2004). https://doi.org/10.1002/lsm.20078 0196-8092 Google Scholar

30. 

B. Choi, L. Tsu, E. Chen, T. S. Ishak, S. M. Iskandar, S. Chess, and J. S. Nelson, “Determination of chemical agent optical clearing potential using in vitro human skin,” Lasers Surg. Med., 36 (2), 72 –75 (2005). https://doi.org/10.1002/lsm.20116 0196-8092 Google Scholar

31. 

V. V. Tuchin, X. Xu, and R. K. Wang, “Dynamic optical coherence tomography in studies of optical clearing, sedimentation, and aggregation of immersed blood,” Appl. Opt., 41 (1), 258 –71 (2002). 0003-6935 Google Scholar

32. 

S. A. Prahl, “The adding-doubling method,” Optical-Thermal Response of Laser-Irradiated, Tissue, 101 –25 Plenum Press, New York (1995). Google Scholar

33. 

Y. He and R. K. Wang, “Improvement of low-level light imaging performance using optical clearing method,” Biosens. Bioelectron., 20 (3), 460 –67 (2004). 0956-5663 Google Scholar
©(2006) Society of Photo-Optical Instrumentation Engineers (SPIE)
Eric Duco Jansen, Patrick M. Pickett, Mark A. Mackanos D.V.M., and Jack Virostko "Effect of optical tissue clearing on spatial resolution and sensitivity of bioluminescence imaging," Journal of Biomedical Optics 11(4), 041119 (1 July 2006). https://doi.org/10.1117/1.2337651
Published: 1 July 2006
Lens.org Logo
CITATIONS
Cited by 33 scholarly publications and 1 patent.
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Skin

In vivo imaging

Bioluminescence

Scattering

Spatial resolution

Tissue optics

Light scattering

Back to Top